Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Vaccines, Inc.”

61 pharma patents match "Takeda Vaccines, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 61
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 61 pharmaceutical patents matching "Takeda Vaccines, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

61 results for “Takeda Vaccines, Inc.” · 30,257 patents in full index Clear search

  1. US 12286456

    Purification of virus like particles

    Takeda Vaccines, Inc. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  2. US 12201683

    Methods for preventing dengue and hepatitis a

    Takeda Vaccines, Inc. · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  3. US 12109260

    Zika vaccines and immunogenic compositions, and methods of using the same

    Takeda Vaccines, Inc. · Granted Oct 8, 2024 · Expires Oct 3, 2044

    granted
  4. US 12018052

    Methods of detection and removal of rhabdoviruses from cell lines

    Takeda Vaccines, Inc. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  5. US 12006341

    Methods of detection and removal of rhabdoviruses from cell lines

    Takeda Vaccines, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  6. US 11975062

    Zika vaccines and immunogenic compositions, and methods of using the same

    Takeda Vaccines, Inc. · Granted May 7, 2024 · Expires May 2, 2044

    granted
  7. US 11964008

    Method for inactivating zika virus and for determining the completeness of inactivation

    Takeda Vaccines, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  8. US 11931399

    Compositions and methods for dengue virus chimeric constructions in vaccines

    Takeda Vaccines, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  9. US 11826415

    Method of conferring a protective immune response to Norovirus

    Takeda Vaccines, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  10. US 11730802

    Zika vaccines and immunogenic compositions, and methods of using the same

    Takeda Vaccines, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  11. US 11701421

    Compositions and methods for stabilizing flaviviruses with improved formulations

    Takeda Vaccines, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted
  12. US 11701420

    Parenteral norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted
  13. US 11648304

    Zika vaccines and immunogenic compositions, and methods of using the same

    Takeda Vaccines, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  14. US 11590221

    Dengue vaccine unit dose and administration thereof

    Takeda Vaccines, Inc. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  15. US 11478541

    Method for inactivating Zika virus and for determining the completeness of inactivation

    Takeda Vaccines, Inc. · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted
  16. US 11464815

    Dengue vaccine unit dose and administration thereof

    Takeda Vaccines, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  17. US 11426461

    Methods for preventing dengue and hepatitis A

    Takeda Vaccines, Inc. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted
  18. US 11286282

    Methods of detection and removal of rhabdoviruses from cell lines

    Takeda Vaccines, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  19. US 11197923

    Methods and compositions for live attenuated viruses

    Takeda Vaccines, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  20. US 11091519

    Purification of virus like particles

    Takeda Vaccines, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  21. US 11040097

    Method of conferring a protective immune response to norovirus

    Takeda Vaccines, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  22. US 11007261

    Compositions and methods of vaccination against dengue virus in children and young adults

    Takeda Vaccines, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  23. US 10835597

    Compositions and methods for stabilizing flaviviruses with improved formulations

    Takeda Vaccines, Inc. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted
  24. US 10806782

    Hand, foot, and mouth vaccines and methods of manufacture and use thereof

    Takeda Vaccines, Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted